Posted Jan. 6, 2012 at 6:51 a.m.
Research Triangle Park, N.C. — If the FDA grants regulatory clearance for a new analyzer that LipoScience calls Vantera, laboratories in hospitals and research facilities across the country could get their own analyzers to conduct the tests at their own sites.Copyright 2013 MedCity. All rights reserved.
LipoScience seeks FDA approval for heart disease risk tests
Post a comment
Print this blog postE-mail blog post
Share
Research Triangle Park, N.C. — If the FDA grants regulatory clearance for a new analyzer that LipoScience calls Vantera, laboratories in hospitals and research facilities across the country could get their own analyzers to conduct the tests at their own sites.Copyright 2013 MedCity. All rights reserved.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows
Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
Triangle politician tries to accelerate crowdfunding; bill passes first hurdle
ChannelAdvisor seeks $80M, sets share target price for IPO
IT job openings 28% below 2012 numbers, report shows















